Injectable Bioengineered Hydrogel Therapy in the Treatment of Ischemic Cardiomyopathy.

about

Injectable Bioengineered Hydrogel Therapy in the Treatment of Ischemic Cardiomyopathy.

Item

http://www.wikidata.org/entity/Q39197932

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Injectable Bioengineered Hydrogel Therapy in the Treatment of Ischemic Cardiomyopathy.

@en

Injectable Bioengineered Hydrogel Therapy in the Treatment of Ischemic Cardiomyopathy.

@nl

type

Item

label

Injectable Bioengineered Hydrogel Therapy in the Treatment of Ischemic Cardiomyopathy.

@en

Injectable Bioengineered Hydrogel Therapy in the Treatment of Ischemic Cardiomyopathy.

@nl

prefLabel

Injectable Bioengineered Hydrogel Therapy in the Treatment of Ischemic Cardiomyopathy.

@en

Injectable Bioengineered Hydrogel Therapy in the Treatment of Ischemic Cardiomyopathy.

@nl

P1476

Injectable Bioengineered Hydrogel Therapy in the Treatment of Ischemic Cardiomyopathy.

@en

P2093

Amanda N Steele

http://www.w3.org/2001/XMLSchema#string

Andrew B Goldstone

http://www.w3.org/2001/XMLSchema#string

Jeffrey E Cohen

http://www.w3.org/2001/XMLSchema#string

John W MacArthur

http://www.w3.org/2001/XMLSchema#string

William Hiesinger

http://www.w3.org/2001/XMLSchema#string

Y Joseph Woo

http://www.w3.org/2001/XMLSchema#string

P2860

Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial

Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial

Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association

Computational protein design to reengineer stromal cell-derived factor-1α generates an effective and translatable angiogenic polypeptide analog.

Proangiogenic scaffolds as functional templates for cardiac tissue engineering.

Rapid casting of patterned vascular networks for perfusable engineered three-dimensional tissues.

Algisyl-LVR™ with coronary artery bypass grafting reduces left ventricular wall stress and improves function in the failing human heart

Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial.

Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial.

Injectable and bioresponsive hydrogels for on-demand matrix metalloproteinase inhibition

P2888

s11936-017-0530-x

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11936-017-0530-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28337717

http://www.w3.org/2001/XMLSchema#string

P921

hydrogel